Medication info

Triamcinolone Injection 50 Milligrams (Triamcinolone Acetonide)

Prescription medicationInjectionsApproval withdrawn
Ingredient · strength
Triamcinolone Acetonide›10mg / 1mL
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
It is an injectable white suspension.
Packaging
10 vials/box [(5 milliliters/vial)]
Approval status
Approval withdrawn

MFDS item code 198800168 · Notified 1988.11.04

This product's status changed to Approval withdrawn on 2025.04.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Intra-articular (e.g., arthritis), intramuscular (e.g., asthma), and intradermal (e.g., alopecia areata) injection treatment
Who uses it
Adults · Children
Adult dosage
1. Intra-articular, intrabursal, and intrasheath injection Adults: The usual dose is 2 ~ 40 mg of triamcinolone acetonide per injection, administered at intervals of at least 2 weeks in principle; adjust the dose as appropriate. 3. Local intradermal injection Adults: The initial dose of this drug varies depending on the disease. However, because administration of large doses may cause local tissue atrophy, inject 0.2 ~ 1 mg at a time, up to 10 mg, once weekly.
Children's dosage
2. Intramuscular injection Pediatric patients 12 years of age and older: The usual initial dose of this drug is 40 mg, injected deep into the gluteal muscle. Adjust the dose within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's therapeutic response. Pediatric patients 6 ~ 12 years of age: An initial dose of 40 mg is appropriate; adjust according to age, body weight, and symptoms. Pediatric patients 6 years of age and younger: Not recommended.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Intra-articular (e.g., arthritis), intramuscular (e.g., asthma), and intradermal (e.g., alopecia areata) injection treatment

  • Synovitis of osteoarthritis
  • rheumatoid-like arthritis
  • acute bursitis
  • subacute bursitis
  • acute gouty arthritis
  • epicondylitis
  • acute tendinitis
  • nonspecific tendinitis
  • post-traumatic osteoarthritis
  • primary adrenal cortical insufficiency
  • secondary adrenal cortical insufficiency
  • psoriatic arthritis
View approved original text

This medicine can be used in various ways. Intra-articular injections are used for short-term treatment of several joint diseases such as osteoarthritis, rheumatoid-like arthritis, and acute gouty arthritis. Intramuscular injections are used to improve symptoms in endocrine disorders, rheumatic diseases, skin diseases, allergies, ocular diseases, gastrointestinal diseases, and blood disorders when oral administration is difficult. Additionally, intradermal injections are applied for the treatment of lichen planus and alopecia areata. Suitable administration methods can be used for various diseases.

Dosage and Administration

Adult dosage

1. Intra-articular, intrabursal, and intrasheath injection Adults: The usual dose is 2 ~ 40 mg of triamcinolone acetonide per injection, administered at intervals of at least 2 weeks in principle; adjust the dose as appropriate. 3. Local intradermal injection Adults: The initial dose of this drug varies depending on the disease. However, because administration of large doses may cause local tissue atrophy, inject 0.2 ~ 1 mg at a time, up to 10 mg, once weekly.

Children's dosage

2. Intramuscular injection Pediatric patients 12 years of age and older: The usual initial dose of this drug is 40 mg, injected deep into the gluteal muscle. Adjust the dose within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's therapeutic response. Pediatric patients 6 ~ 12 years of age: An initial dose of 40 mg is appropriate; adjust according to age, body weight, and symptoms. Pediatric patients 6 years of age and younger: Not recommended.

Precautions

This medication is in suspension form and should not be used for intravenous injection. Injecting into the epidural or spinal canal is also very dangerous and may cause serious side effects, hence should be avoided. This medication contains benzyl alcohol, which can cause severe respiratory problems in premature infants or neonates. Therefore, it should not be used in such patients. It is safe not to administer this medication to patients who have had allergic reactions to it, those with severe infections, those with certain blood disorders, and those with viral infections such as herpes simplex or varicella. It should also be avoided in cases of joint or bursal infection, in patients with unstable joints, and in neonates or preterm infants. Patients with specific diseases, such as tuberculosis, glaucoma, hypertension, diabetes, osteoporosis, and heart disease, must be very cautious when using this medication, using the minimum dose only when necessary. This medication can cause various side effects including fluid retention, hypertension, muscle weakness, osteoporosis, gastrointestinal disorders, skin problems, neurological and endocrine changes, eye diseases, blood abnormalities, and respiratory issues, therefore symptoms should be closely monitored during use. As this medication suppresses immune function, the risk of infections can increase, and care should be taken to avoid exposure to infections such as varicella or measles, and immediate medical attention should be sought if infection is suspected. Long-term use may lead to adrenal insufficiency, and sudden discontinuation can be hazardous, hence the dosage should be gradually reduced. This medication may interact with various other drugs; hence patients should consult a doctor or pharmacist if they are taking other medications. Women who are pregnant or possibly pregnant should only use it when absolutely necessary, as it may affect the fetus, and it is advisable to avoid using it while breastfeeding. In pediatric patients, side effects such as growth delay can occur, so it should be used cautiously in the minimum effective dose, and elderly patients also require careful monitoring due to the elevated risk of side effects. Finally, this medication should not be administered via specific injection methods such as intravenous injection, intrathecal injection, or epidural injection, and intramuscular injections should be done safely while avoiding nerve or vascular areas.

Side effects

Fluid retention, sodium retention, congestive heart failure, potassium loss, ECG changes due to venous dysfunction or potassium deficiency, hypertension, edema, myalgia, arthralgia, muscle weakness, fatigue, steroid myopathy, loss of muscle mass, osteoporosis, vertebral compression fractures, delayed healing of fractures, aseptic necrosis of the femoral and humeral heads, pathological fractures of the iliac bone, idiopathic fractures, tendon rupture, gastric perforation digestive ulcer, pancreatitis, diarrhea, nausea, vomiting, abdominal pain, heartburn, abdominal distention, ulcerative esophagitis, thirst, loss of appetite, increased appetite, dyspepsia, abdominal bloating, gastrointestinal dysfunction, bladder dysfunction, delayed wound healing, epidermal peeling, petechial hemorrhage, facial erythema, hyperhidrosis, purpura, hirsutism, acneiform rash, lesions resembling erythematous lupus, suppression responses in skin tests, hair loss, lipodystrophy, convulsions, congestion, increased intracranial pressure associated with papilledema, dizziness, headache, neuritis or paresthesia, euphoria, insomnia, arachnoiditis, meningitis, incomplete paraplegia, complete paraplegia, sensory disturbances, spinal cord infarction, paraplegia, quadriplegia, cortical visual loss, stroke, menstrual irregularities, postmenopausal vaginal bleeding, Cushing's syndrome, growth suppression in children, secondary adrenal cortex and pituitary non-responsiveness, decreased glucose tolerance, onset of latent diabetes, increased responsiveness to insulin or oral hypoglycemic agents, buffalo hump, suppression of adrenocorticotropic hormone secretion, elevated intraocular pressure, glaucoma, posterior subcapsular cataract, secondary eye infections, central serous chorioretinopathy, retinal disorders, proptosis, leukocytosis, thrombosis, hyperglycemia, diabetes, negative nitrogen balance due to protein catabolism, exacerbation of bronchial asthma, shock, anaphylactoid reactions, dyspnea, generalized flushing, angioedema, urticaria, joint destabilization, pain, increased tenderness, worsening of swelling, local tissue atrophy, retinal artery occlusion, blindness, visual disturbances, hepatitis, sclerodermic renal growth, vasculitis, thrombophlebitis, thrombosis, exacerbation of infections, masking of infections, syncope

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that does not allow light in. Additionally, to maintain the drug's effectiveness, it is advisable to store it at room temperature, that is, in a typical room temperature that is not too hot or cold.

Appearance and packaging

Appearance

It is an injectable white suspension.

Package unit

10 vials/box [(5 milliliters/vial)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.